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Resveratrol Increases Cathelicidin Expression and Offers a Novel Approach to
Combat Staph aureus Invasion
Shivtaj Mann DO and Kyle Kreitman DO
Department of Internal Medicine, Lehigh Valley Health Network, Allentown, Pennsylvania

INTRODUCTION
•	Cathelicidin(CAMP), an antimicrobial peptide, is commonly described in literature
as a byproduct of the Vit D receptor pathway and is a key component of the
epidermal barrier. The epidermal barrier is a refined product of billions of years
of evolution that serves to protect vital tissues from microbial pathogens and
mechanical damage.
•	We previously described a novel, VitD receptor independent pathway that
showcased the role of sphingosine-1-phosphate (S1P) in de novo production of
cathelicidin. Moreover, we have also shown that keratinocytes prevent apoptosis
by de novo production of sphingomyelin from ceramide.
•	Here, we investigate if ceramide expression can be induced by resveratrol (RESV),
a polyphenol known to increase ceramide expression, and if induced ceramide can
modulate downstream cathelicidin production in order to enhance the innate skin
barrier and combat staph aureus invasion.

RESULTS
•	RESV group maintained epidermal integrity.
•	Topical RESV increased CAMP production in murine skin compared to control, p<.01.
•	This increased production is secondary to activation of NF-KB pathway as revealed by:

			•	
Increased phosphorylation of NF-KB (marker of activation) in the RESV group.
			•	
Attenuation of phospho-NF-KB by introduction of SKI.
			•	
Attenuation of CAMP production with introduction of BAY11-7082, a NF-KB inhibitor, in cultured keratinocytes.

•	RESV prevents invasion of Staph aureus into the epidermal barrier.

D. Western blot technique confirms increased
expression of CAMP protein w/ RESV application. Beta
actin serves as a control.

METHODS
•	We used the well established oxazolone (Ox) model to perturb the epidermal skin
barrier and study the effects of cathelicidin production in restoring the skin barrier
and combating staph aureus penetration/invasion.
•	Six mice model groups were created using the hairless SKH1 mice, including two
control groups:
•	RESV was applied to the flanks of the mice 2x/day for 21 days. Skin samples were
obtained at the end of the 21 day period. qT-PCR and Western blot techniques were
used on homogenized skin samples in order to quantify cathelicidin expression.
•	Further, NF-KB receptor assay was utilized to assess whether RESV increased
activation of the NF-KB nuclear transcription factor.Finally, skin tissue biopsies
were gram stained to investigate
Study Groups
the effects of cathelicidin in
Experimental
Control
preventing invasion of Staph 
aureus into and through the
EtOH (ethanol)
Ox + EtOH
innate skin barrier. Statistical
Ox + SKI
comparisons were performed
Sphingosine-kinase-inhibitor (SKI)
Ox + RESV
using an unpaired Student t-Test.
Ox + RESV + SKI
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B. RESV application prevents thickening of epidermis and
thus maintains the epidermal barrier.

C. Topical RESV increased CAMP production in
murine skin compared to control, p<.01.

A. Haemotoxylin and Eosin stain of murine skin with
application of RESV and EtOH (vehicle).
E. Introduction of RESV increases phosphorylation of NFKB. This is represents activation of NF-KB. The western
blot shows increased intensity of Ser337 in the RESV
group. Serr37 is an antibody against phospho-NF-KB.
This intensity is reduced with introduction of SKI.

F. Introduction of BAY11-7082, an inhibitor
of NF-KB, markedly reduces CAMP mRNA
production.

A. Introduction of LL-37, which is the active form of CAMP
in-vivo, to cultured keratinocytes inhibited growth of Staph
aureus. In a similar fashion, RESV also inhibited growth of
Staph aureus.
B. RESV increased CAMP production.
C. H&E stain of murine biopsies colonized with Staph
aureus. RESV group prevented invasion of Staph aureus.
This effect was neutralized with co-application of SKI.

CONCLUSIONS
•	Our results display strong evidence that:
			•	
RESV increases CAMP production.
			•	
CAMP upregulation follows the activation cascade ceramide→sphingosine→ S1P metabolism and is mediated
via NF-KB activation.
			•	
CAMP modulation offers a novel method to combat Staph aureus invasion in an era of ever-increasing
antimicrobial resistance.
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